Advert - Biogen Idec – Case AUTH/3575/11/21

• Date posted
  12 December 2022
• Sanction
  Advertisement,
• Case number/s
  AUTH/3575/11/21 - Ex-employee v Biogen

For a local senior leader, who had since left Biogen Idec, sending an email to a broad internal audience in 2018, which linked a fundraising activity with the work that the recipient charities were doing with Biogen Idec in relation to Spinraza (nusinersen sodium), Biogen Idec was ruled in breach of the following clauses of the 2016 Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 9.1 - Failing to maintain high standards